2 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
Follow Peripheral T Cell Lymphoma: new trials by email Literature Review of Peripheral T Cell Lymphoma trials Research Report on Peripheral T Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas cisplatin, ifosfamide, gemcitabine - Peripheral T Cell Lymphoma | Phase 4 | Unknown | The University of Hong Kong | 50 | 2017-02-24 | 2018-06-11 |
| A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy Pralatrexate - Peripheral T Cell Lymphoma, Progression, Disease | Phase 4 | Unknown | Taiwan Mundipharma Pharmaceuticals Ltd. | 22 | 2016-08-30 | 2017-05-12 |
Lymphoma, T-Cell, Peripheral (2) · Disease Progression (1)
Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Lymphoma, T-Cell (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
10-propargyl-10-deazaaminopterin (1) · Asparaginase (1) · Cisplatin (1) · Dexamethasone (1) · Etoposide (1) · Gemcitabine (1) · Ifosfamide (1)
Taiwan Mundipharma Pharmaceuticals Ltd. (1) · The University of Hong Kong (1)
Hong Kong (1) · Taiwan (1)
Bor-Sheng Ko, PhD (1) · Yok Lam Kwong, MBBS (1)